Dyadic International, Inc. vs. Repligen Corp
Dyadic International, Inc. and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| DYAI | RGEN | |
|---|---|---|
| Market Cap | $32.07 million | $9.35 billion |
| Revenue (TTM) | — | $785.10 million |
| Net Income (TTM) | — | $41.54 million |
RGEN leads on 1 of 1 size & scale factors.
Valuation
| DYAI | RGEN | |
|---|---|---|
| P/E Ratio | — | 228.53 |
| Price / Book | — | 4.43 |
| Price / Sales | — | 11.91 |
DYAI and RGEN split the valuation factors evenly.
Profitability
| DYAI | RGEN | |
|---|---|---|
| Net Margin | — | 5.29% |
| Return on Equity | — | 1.97% |
DYAI and RGEN split the profitability factors evenly.
Risk & Sentiment
| DYAI | RGEN | |
|---|---|---|
| Short Interest | 0.01% | 7.13% |
DYAI leads on 1 of 1 risk & sentiment factors.
Dig deeper: DYAI overview, DYAI financials, RGEN overview, RGEN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.